The Canadian Biomarker Integration Network in Depression (CAN-BIND) study protocol utilizes an ECT-like approach to intravenous ketamine, consisting of an acute treatment period of thrice-weekly doses followed by maintenance doses that decrease in frequency over six months, moving from weekly to monthly intervals.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (1)

• ketamine concept